Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-1897-2026

XTANT Medical Holdings, Inc recalls nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute…

XTANT Medical Holdings, IncBelgrade, MT, United StatesReported Apr 29, 2026 · 2 months ago
Legal News Analyst ·

Reason for recall

Products were incorrectly labeled with a 5-year shelf life. The approved and validated shelf life is four years.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • nanOss 3D Advanced Bone Graft Substitute nanOss 3D Plus Advanced Bone Graft Substitute 90-300-251008: nanOss 3D Advanced Bone Graft Substitute, 25x100x8mm, 20cc 90-300-25508: nanOss 3D Advanced Bone Graft Substitute, 25x50x8mm, 10cc 90-300-251004: nanOss 3D Advanced Bone Graft Substitute, 25x100x4mm, 10cc 90-400-25508: nanOss 3D Plus Advanced Bone Graft Substitute, 25x50x8mm, 10cc
    UDI-DI 00849777012478
    23 affected lots
    385486-RP25-0080387070-RP25-0081415971-RP25-0077436563-RP25-0082436564-RP25-0079436565-RP25-0076444927-RP25-007890-300-25508
    +15 more00849777012492387071-RP25-0083418098-RP25-0084436199-RP25-008590-300-25100400849777012461401347-RP25-0070415871-RP25-0073415872-RP25-0074416678-RP25-0072416679-RP25-0071418509-RP25-007590-400-2550800849777012539445442-RP25-0128

What the firm is doing

On March 9, 2026, the firm began notifying customers via letters titled "URGENT: MEDICAL DEVICE RECALL." Customers were instructed to segregate and quarantine all affected products to prevent use, and discontinue use of any affected product. Affected product must be returned to Xtant Medical.

DistributionShow details

US Nationwide distribution in the states and territories of CA, CT, DC, KS, MD, NC, NY, TX, and WI.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls